ArticleBMC cancer2024

Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancer.

Xing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.